(Q43734626)

26 November 2017

title

Confusion and dysphoria with low-dose topiramate in a patient with bipolar disorder (English)

1 reference

26 November 2017

1 reference

1 reference

C Andrade

1

1 reference

26 November 2017

publication date

1 August 2001

1 reference

26 November 2017

number of pages

2

1 reference

inferred from page(s)

published in

Bipolar Disorders

1 reference

26 November 2017

volume

3

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

211-212

1 reference

Open-label adjunctive topiramate in the treatment of bipolar disorders.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30406.X

Effects of topiramate on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30406.X

Mood stabilization and weight loss with topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30406.X

Topiramate as add-on treatment for patients with bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30406.X

7 January 2021

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30406.X

1 reference

7 January 2021

A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30406.X

7 January 2021

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-5618.2001.30406.X

7 January 2021

10.1034/J.1399-5618.2001.30406.X

Identifiers

DOI

1 reference

26 November 2017

1 reference